Screening for cervical neoplasia by self-assessment for human papillomavirus DNA

Lancet

Volumn 354, Issue 9194, 1999, Pages 1970-

  Hillemanns, Peter ^a   Kimmig, Rainer ^a   Hüttemann, Ulrike ^a   Dannecker, Christian ^a   Thaler, Christian J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER SCREENING; CLINICAL TRIAL; FEMALE; HIGH RISK POPULATION; HUMAN; PRIORITY JOURNAL; SELF EVALUATION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

EID: 0344991653     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)04110-0     Document Type: Article

References (3)

1. Bosch F.X., Manox M.M., Munoz N.et al. Prevalence of human papillomavirus in cervical cancer: worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 87:1995;779-780.
2. Cuzick J., Szarewski A., Terry G.et al. Human papillomavirus testing in primary cervical screening. Lancet. 345:1995;1533-1536.
3. Soost H.J., Lange H.J., Lehmacher W., Ruffing-Kullmann B. The validation of cervical cytology. Sensitivity, specificity and predictive values. Acta Cytol. 35:1991;8-14.